69 related articles for article (PubMed ID: 11710288)
1. [Features of immunologic and virusologic indicators in oncology patients].
Sevost'ianova NV; Isaeva TM; Urazova LN
Vopr Onkol; 2001; 47(4):446-8. PubMed ID: 11710288
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in head and neck cancer assessed by quantitative polymerase chain reaction.
Goldenberg D; Benoit NE; Begum S; Westra WH; Cohen Y; Koch WM; Sidransky D; Califano JA
Laryngoscope; 2004 Jun; 114(6):1027-31. PubMed ID: 15179207
[TBL] [Abstract][Full Text] [Related]
4. Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.
Kuss I; Schaefer C; Godfrey TE; Ferris RL; Harris JM; Gooding W; Whiteside TL
Clin Immunol; 2005 Jul; 116(1):27-36. PubMed ID: 15925829
[TBL] [Abstract][Full Text] [Related]
5. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
[TBL] [Abstract][Full Text] [Related]
6. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
Sinha R; Gupta SC; Naithani YP
Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
[No Abstract] [Full Text] [Related]
7. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
8. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
9. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
[TBL] [Abstract][Full Text] [Related]
10. Long-term immune dysfunction after radiotherapy to the head and neck area.
Verastegui EL; Morales RB; Barrera-Franco JL; Poitevin AC; Hadden J
Int Immunopharmacol; 2003 Aug; 3(8):1093-1104. PubMed ID: 12860166
[TBL] [Abstract][Full Text] [Related]
11. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of poor CD3 response in head and neck cancer.
Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
[TBL] [Abstract][Full Text] [Related]
13. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
14. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
15. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
Koukourakis GV; Baksevanis CN; Zambatis H; Gritzapis A; Maltezos E; Simopoulos C; Koukourakis MI
Int J Radiat Biol; 2009 Jan; 85(1):96-104. PubMed ID: 19205988
[TBL] [Abstract][Full Text] [Related]
16. [Clinical assessment of the patients with head and neck cancers using hematological serological and immunological parameters (author's transl)].
Okamoto M
Nihon Jibiinkoka Gakkai Kaiho; 1981 Nov; 84(11):1408-23. PubMed ID: 6977628
[No Abstract] [Full Text] [Related]
17. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
19. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
Strauss L; Volland D; Kunkel M; Reichert TE
Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
[TBL] [Abstract][Full Text] [Related]
20. Immunobiology of head and neck cancer.
Whiteside TL
Cancer Metastasis Rev; 2005 Jan; 24(1):95-105. PubMed ID: 15785875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
